Regeneron Pharmaceuticals
Regeneron Pharmaceuticals (REGN) is included in the current HalalSignalz stock passlist as of June 4, 2026. This is an educational passlist snapshot, not a fatwa, personal financial advice, or a permanent status guarantee.
On HalalSignalz halal stock passlist
Screen: AAOIFI. Category: Healthcare & Biotech.
Regeneron Pharmaceuticals develops and sells biotechnology medicines for eye disease, immunology, oncology, rare diseases, and related therapeutic areas.
Quote Pulse
Regeneron Pharmaceuticals · Healthcare & Biotech
Pulse score
Pulse score locked
Create a free account to see this ticker's Pulse Score and setup band. No credit card.
Market Pulse is educational market context only. It is not a halal verdict, buy signal, forecast, or personalized financial advice. Not a buy signal or trade instruction.
Latest cached quote 2026-06-05; refreshed about every 5 minutes. Educational context from the latest cached quote only. This graph is not a buy signal, not a forecast, and not personalized financial advice; you decide manually in your broker.
Balanced unlocks the price path, entry map, stop, target, and signal-readiness layers.
Upgrade to seeEntry area
Upgrade to see
Stop
Upgrade to see
Target
Upgrade to see
Balanced unlocks entry, stop, target, and invalidation context for manual review.
Locked levels stay hidden until paid access; the public graph remains educational market context only.
Balanced unlocks the entry area, stop, target, and invalidation map before you decide manually.
Regeneron Pharmaceuticals is screened as a stock. The analysis combines market regime, sector strength, technical setup, sentiment, fundamentals, halal status, and risk-defined levels for an educational decision review.
Quick read
Neutral watch
1-month move: -14.4%
Latest price
$628.73
Latest available market quote, last updated Jun 5, 2026, 5:21 AM UTC. We check for an updated feed about every 5 minutes; it is not a live-streaming price.
Start with the Free account for research tools. Balanced includes Free and adds the full ticker-specific read.
First step
Use Free to keep researching before choosing a paid plan.
Paid analysis
Includes Free, plus the full core read for this ticker.
Balanced provides
Balanced replaces the checklist outline with the ticker-specific values and interpretation.
No card. Save tickers first, then upgrade when you want the full paid read.
Balanced provides
Free shows the broad setup band: Mixed setup profile. Balanced shows the score and why it landed there.
Balanced provides
Balanced turns the research read into a manual review map before you decide in your own broker.
Halal screen
On HalalSignalz halal stock passlist
Screening snapshot: AAOIFI.
Educational analysis only. HalalSignalz is not a broker, custodian, fund, or automated trading system; you decide and place any trade manually.
These notes summarize the screening basis, the items worth rechecking, and the detailed interpretation behind this passlist entry.
Healthcare & Biotech business activity reviewed as part of the current passlist.
REGN being present on this passlist only answers the first screening question. Check these before treating Regeneron Pharmaceuticals as investable for your own portfolio.
Regeneron Pharmaceuticals is treated here as a healthcare & biotech stock first, then as a market ticker second. The screening snapshot starts with the business line, because a low debt ratio does not make a company suitable if the core revenue stream is impermissible. The current page therefore pairs the verdict with a plain-language description of what Regeneron Pharmaceuticals sells, the screening source used, and the ratio fields that should be refreshed after each new filing.
For stock investors, the important follow-up is not only whether REGN appears on a halal list. Debt, cash, interest income, acquisition activity, and segment mix can all move between quarterly reports. The passlist result is a dated educational screen as of June 4, 2026; it should be rechecked against the latest 10-Q, 10-K, or annual report before a new position is opened or an existing holding is increased.
This page also separates Shariah screening from trade timing. A company can pass the HalalSignalz screen while still being expensive, technically weak, or too volatile for a particular account. The chart, related companies, and recheck list help compare REGN with nearby halal candidates, while the Balanced analysis adds the company fundamentals read before timing and risk levels are reviewed.
Compare REGN with nearby passlist names so the halal screen, business activity, and timing context are not reviewed in isolation.
The current HalalSignalz verdict for REGN is: On HalalSignalz halal stock passlist. This June 4, 2026 stock passlist snapshot uses AAOIFI screening context.
No. This page is an educational halal-screening snapshot for Regeneron Pharmaceuticals; investors still need to review valuation, timing, liquidity, risk size, and their own scholar or advisor guidance.
Regeneron Pharmaceuticals should be rechecked against fresh filings, business changes, market conditions, and any purification requirements before making an investment decision.